Toxin-Induced Cardiovascular Failure

被引:15
|
作者
Jang, David H. [1 ]
Spyres, Meghan B. [2 ]
Fox, Lindsay [3 ]
Manini, Alex F. [4 ]
机构
[1] NYU, Div Med Toxicol, Dept Emergency Med, Sch Med, New York, NY 10016 USA
[2] NYU, Sch Med, New York, NY 10016 USA
[3] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Div Med Toxicol, Dept Emergency Med, Elmhurst Hosp Ctr, New York, NY 10029 USA
关键词
beta-blocker; Cardiac arrest; Cardiac injury; Calcium channel blocker; Digoxin; Dysrhythmia; Overdose; HIGH-DOSE INSULIN; INTRAVENOUS LIPID EMULSION; CHANNEL BLOCKER OVERDOSE; FAB ANTIBODY FRAGMENTS; MYOCARDIAL-INFARCTION; SUCCESSFUL RESUSCITATION; POSSIBLE ASSOCIATION; DRUG-OVERDOSE; UNITED-STATES; COCAINE USE;
D O I
10.1016/j.emc.2013.10.003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Adverse cardiovascular events comprise a large portion of the morbidity and mortality in drug overdose emergencies. Adverse cardiovascular events encountered by emergency physicians treating poisoned patients include myocardial injury, hemodynamic compromise with shock, tachy-dysrhythmias, and cardiac arrest. Early signs of toxin-induced cardiovascular failure include bradycardia, tachycardia, and specific ECG findings. Treatment of toxicologic tachycardia relies on rapid supportive care along with proper use of benzodiazepines for sedation. Treatment of toxicologic bradycardia consists of the use of isotonic fluids, atropine, calcium salts, and glucagon. High-dose insulin euglycemia should be used early in the course of suspected severe poisoning and intravenous lipid emulsion given to patients who suffer cardiac arrest.
引用
收藏
页码:79 / +
页数:25
相关论文
共 50 条
  • [31] The role of Fats in toxin-induced demyelination
    Hesse, Amke R.
    Held, Jasmin
    Waisman, Ari
    Kuhlmann, Tanja
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S272 - S272
  • [32] BOTULINUM TOXIN-INDUCED MYOPATHY IN THE RAT
    HASSAN, SM
    JENNEKENS, FGI
    VELDMAN, H
    [J]. BRAIN, 1995, 118 : 533 - 545
  • [33] DRUG- AND TOXIN-INDUCED RHABDOMYOLYSIS
    Camp, Nancy E.
    [J]. JOURNAL OF EMERGENCY NURSING, 2009, 35 (05) : 481 - 482
  • [34] TOXIN-INDUCED PARKINSONISM - RECENT DEVELOPMENTS
    FRUNCILLO, RJ
    [J]. AMERICAN FAMILY PHYSICIAN, 1986, 33 (03) : 251 - 254
  • [35] Drug- and toxin-induced hepatotoxicity
    Grünhagel, F
    Fischer, HP
    Sauerbruch, T
    Reichel, C
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (06): : 565 - 578
  • [36] Uraemic toxin-induced platelet hyperactivity
    Allison, Susan J.
    [J]. NATURE REVIEWS NEPHROLOGY, 2017, 13 (05) : 261 - 261
  • [37] Uraemic toxin-induced platelet hyperactivity
    Susan J. Allison
    [J]. Nature Reviews Nephrology, 2017, 13 : 261 - 261
  • [38] Serotonin as a biomarker of toxin-induced Parkinsonism
    Buchanan, Anna Marie
    Mena, Sergio
    Choukari, Iman
    Vasa, Aditya
    Crawford, Jesseca N.
    Fadel, Jim
    Maxwell, Nick
    Reagan, Lawrence
    Cruikshank, Allie
    Best, Janet
    Nijhout, H. Fred
    Reed, Michael
    Hashemi, Parastoo
    [J]. MOLECULAR MEDICINE, 2024, 30 (01)
  • [39] Drug- and toxin-induced myopathies
    Fürer, V
    Reichmann, H
    [J]. AKTUELLE NEUROLOGIE, 2006, 33 (03) : 124 - 129
  • [40] Serotonin as a biomarker of toxin-induced Parkinsonism
    Anna Marie Buchanan
    Sergio Mena
    Iman Choukari
    Aditya Vasa
    Jesseca N. Crawford
    Jim Fadel
    Nick Maxwell
    Lawrence Reagan
    Allie Cruikshank
    Janet Best
    H. Fred Nijhout
    Michael Reed
    Parastoo Hashemi
    [J]. Molecular Medicine, 30